Parvovirus B19 infection: New pathophysiological perspectives;Infection par le parvovirus B19: Nouvelles approches physiopathologiques

Presse Medicale

Volumn 25, Issue 4, 1996, Pages 162-166

  Labau, E ^a   Bonnet, E ^a   Alric, L ^a   Massip, P ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR;

CELL CYCLE; CELL DEATH; HUMAN; PARVOVIRUS; PATHOPHYSIOLOGY; SHORT SURVEY; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ARTHRITIS; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; MALE; PARVOVIRUS B19, HUMAN; PREGNANCY; PURPURA; RED-CELL APLASIA, PURE; VIRULENCE;

EID: 0030054242     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Owren PA. Congenital hemolitic jaundice The pathogenesis of the ≪hemolitic crisis≫. Blood 1948 ; 3:231-48.
2. Anderson MJ, Higgins PG, Davis LR et al. Experimental parvoviral infection in humans. J Infect Dis 1985 ; 152:257-64.
3. Potter CG, Potter AC, Hatton CSR. Variation of erythroid and myeloid precursors in the marrow and periferal blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest 1987 ; 79:1486-92.
4. Clewley JP. Polymerase chain reaction asay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 1989 ; 27:2647-51.
5. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993 ; 262:114-17.
6. Brown KE, Hibbs JR, Gallinella G et al. Resistance to parvovirus infection due to lack of virus receptor (Erythrocyte P antigen). Lancet 1994 ; 330:1192-6.
7. Srivastava A, Bruno E, Briddell R. Parvovirus B19-induced perturbation of human megacaryocytopoiesis in vitro. Blood 1990 ; 76:1997-2004.
8. Morey AL, Porter HJ, Keeling JW, Fleming KA. Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human foetal parvovirus infection. J Clin Pathol 1992 ; 45:673-8.
9. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blease RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989 ; 84:114-23.
10. Bowman CA, Cohen BJ, Norfolk DR, Lacey CJN. Red cell aplasia associated with human parvovirus B19 and HIV infection failure to respond clinically to intravenous immunoglobulins. AIDS 1990 ; 4:1038-9.
11. Frickhofen N, Young NS. Persistant parvovirus B19 infections in humans. Microbiol Pathogen 1989 ; 7:319-27.
12. Kandolf R, Kirshner P, Hofscheider PH. Detection of parvovirus in a patient with ≪reactive arthritis≫ by in vitro hybridization. Clin Rheumatol 1989 ; 8:398-401.
13. Dijkmans B, Van Elsacker-Niele AMW, Salimans MMM, Van Albada-Kuipers GA, De Vries E, Weiland HT. Human parvovirus in synovial fluid. Arthritis Rheum 1988 ; 31:279-81.
14. Ueno Y, Umadome H, Shimodera M, Kishimotot I, Ikegaya K, Yamaushi T. Human parvovirus B19 and arthritis. Lancet 1993 ; 341:1280.
15. Klouda PT, Corbin SA, Bradley BA. HLA and acute arthritis following human parvovirus infection. Tissue Antigens 1989 ; 28:318-19.
16. Woolf AD, Campion GV, Chishick A. Clinical manifestations of human parvovirus infection in adults. Arch Intern Med 1989 ; 149:1153-6.
17. Labau E, Henry S, Massip P, Icart J, Beaudou J, Didier J Etude critique du diagnostic biologique des parvoviroses de l'adulte. A propos de 16 observations. Présenté au 4e congrès national de la société française de Microbiologie, Tours, France, 2-5 mai 1995
18. Soloninka CA, Anderson MJ, Laskin CA. Autoantibodies in sera from patients with parvovirus B19 infection. J Rheumatol 1990 ; 17:416.
19. Sasaki T, Takahashi Y, Yoshinaga. An association between human parvovirus B19 infection and auto-antibody production J Rheumatol 1989 ; 16:708-9.
20. Cassinotti P, Bas S, Siegl G, Visher TL. Human parvovirus detection in blood or synovial fluid from patients with arthritis. Presented at the 1994 Joint Meeting of the European Group for Rapid Viral Diagnosis, Society Against Viral Diseases, Stockholm, Sweden, 14-18 August 1994.
21. Foto F, Saag KG, Scharosch LL, Howard EJ, Naides SJ. Parvovirus B19 specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistance. J Infect Dis 1993 ; 167:744-8.
22. Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet 1988 ; i:535-6
23. Knisely AS. Parvovirus infection in the fetus. Lancet 1990 ; 336:443.
24. Metzman R, Anand A, DeGiulio PA. Hepatic disease associated with intrauterine parvovirus B19 intrauterine infection in a newborn premature infant. J Pediatr Gastroenterol Nutr 1989 ; 9:112-14.
25. Franctosi RA, Tattersall P. Fetal infection with human parvovirus B19. Hum Pathol 1988 ; 19:489-91.
26. Finkel TH, Torök TJ, Ferguson PJ et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994 ; 343:1255-8.